Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a ...

Four years after remission from follicular lymphoma, ongoing fear of relapse, lingering symptoms, and life stressors continue ...

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

Lymphoma Research Foundation and Follicular Lymphoma Innovation (IFLI) announce major investment to host 2026 International Scientific Workshop to advance research and innovation in follicular ...

Watchful waiting—also known as active surveillance—is a common approach for asymptomatic, advanced stage follicular lymphoma, ...

Celebrity Esthetician, Key Opinion Leader and Melanoma Supporter and Advocate Joins the Melanoma Research Foundation's #GetNaked Campaign to Promote Sun Safety, Protected Skin and Melanoma Prevention ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

TheraLight, LLC, a leading innovator in photomedicine technology, announces the upcoming release of the TheraLight FIT, an advanced full-body red light therapy bed specifically engineered for standard ...

Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.